Boston Scientific WATCHMAN FLX Pro Study Meets Primary Endpoints
Six-month data showed aspirin alone and reduced-dose NOAC each achieved non-inferiority to dual anti
Six-month data showed aspirin alone and reduced-dose NOAC each achieved non-inferiority to dual anti